Dems Flail Over Pharma Cash And Drug Pricing Vote | WHAT REALLY HAPPENED X-Frame-Options: SAMEORIGIN

Dems Flail Over Pharma Cash And Drug Pricing Vote

Conservative Democratic Reps. Scott Peters (Calif.) and Kurt Schrader (Ore.) have been defending their huge hauls of campaign cash from the pharmaceutical industry since announcing their opposition to House Democrats’ wildly popular plan to reduce drug prices. Meanwhile, another Democratic lawmaker, Rep. Kathleen Rice (N.Y.), has completely flipped her reasoning for why she voted against the measure.

Last week, Schrader, Peters, and Rice used their seats on the House Energy and Commerce Committee to try to block House Democrats from allowing Medicare to use its bulk purchasing power to negotiate lower prescription drug prices as part of the party’s $3.5 trillion infrastructure reconciliation effort. The proposal has support from 90 percent of registered voters in their districts, according to a recent poll by Data For Progress.

Comments

SHARE THIS ARTICLE WITH YOUR SOCIAL MEDIA